title: Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette.
abstract: We have constructed two new adenovirus expression cassettes that expand both the range of genes which can be expressed with adenovirus vectors (AdV) and the range of cells in which high-level expression can be attained. By inclusion of a tetracycline-regulated promoter in the transfer vector pAdTR5, it is now possible to generate recombinant adenoviruses expressing proteins that are either cytotoxic or that interfere with adenovirus replication. We have used this strategy to generate a recombinant adenovirus encoding a deletion in the R1 subunit [R1(delta2-357)] of the herpes simplex virus type 2 ribonucleotide reductase. Cell lines expressing the tetracycline-regulated transactivator (tTA) from an integrated vector or following infection with an AdV expressing tTA are able to produce deltaR1 protein at a level approaching 10% total cell protein (TCP) when infected with Ad5TR5 deltaR1 before they subsequently die. To our knowledge, this is the first report of the overexpression of a toxic gene product with AdV. We have also constructed a new constitutive adenovirus expression cassette based on an optimized cytomegalovirus immediate-early promoter-enhancer that allows the expression of recombinant proteins at a level greater than 20% TCP in nonpermissive cell lines. Together, these new expression cassettes significantly improve the utility of the adenovirus system for high-level expression of recombinant proteins in animal cells and will undoubtedly find useful applications in gene therapy.
authors.affiliation: Institut de Recherches en Biotechnologie, Montréal, Québec, Canada. Bernard.Massie@NRC.ca
authors.forename: B
authors.initials: B
authors.lastname: Massie
authors.forename: F
authors.initials: F
authors.lastname: Couture
authors.forename: L
authors.initials: L
authors.lastname: Lamoureux
authors.forename: D D
authors.initials: DD
authors.lastname: Mosser
authors.forename: C
authors.initials: C
authors.lastname: Guilbault
authors.forename: P
authors.initials: P
authors.lastname: Jolicoeur
authors.forename: F
authors.initials: F
authors.lastname: Bélanger
authors.forename: Y
authors.initials: Y
authors.lastname: Langelier
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D002461:Cell Line, Transformed; D003001:Cloning, Molecular; D015870:Gene Expression; D005822:Genetic Vectors / Q000235:genetics*; D006367:HeLa Cells; D017405:Herpes Simplex Virus Protein Vmw65 / Q000235:genetics*; D006801:Humans; D017346:Protein Serine-Threonine Kinases / Q000096:biosynthesis* / Q000235:genetics / Q000633:toxicity; D012097:Repressor Proteins / Q000235:genetics*; D012264:Ribonucleotide Reductases / Q000096:biosynthesis* / Q000235:genetics / Q000633:toxicity; D013752:Tetracycline; D014407:Tumor Cells, Cultured
chemical_list: D017405:Herpes Simplex Virus Protein Vmw65; D012097:Repressor Proteins; C034811:tetracycline resistance-encoding transposon repressor protein; C100671:ICP10 protein, herpes simplex virus type 2; D012264:Ribonucleotide Reductases; D017346:Protein Serine-Threonine Kinases; D013752:Tetracycline